Logo

Myriad Genetics: UroSuite

Nov 10, 2022

Myriad Genetics launched UroSuite, a suite of prostate cancer genetic risk assessment tests. The suite includes the Polaris Prostate Cancer Test, MyRisk Hereditary Cancer Test, BRACAnalysis CDx, and Precise Tumor Molecular Profile Test. UroSuite enables providers to order multiple Myriad tests and receive a one-sheet summary of results through an online portal, use Myriad's Precise Treatment Registry health data platform, and connect with genetic counselors and clinical experts.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find structural network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.